Kestra Medical Technologies, Ltd. SEC filings KMTS
Kestra Medical Technologies, Ltd. has 187 filings in SEC EDGAR's recent list, going back to Aug 25, 2021. Its latest annual report, Form ARS, was filed on Jul 28, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 14, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (results of operations). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Apr 1, 2026 | — |
| S-8 | Employee stock plan registration | Mar 18, 2026 | — |
| 424B4 | Prospectus | Dec 3, 2025 | — |
| S-1MEF | Filing | Dec 2, 2025 | — |
| S-1 | Registration statement | Dec 1, 2025 | — |
| S-8 | Employee stock plan registration | Mar 7, 2025 | — |
| 424B4 | Prospectus | Mar 6, 2025 | — |
| S-1MEF | Filing | Mar 5, 2025 | — |
| S-1/A | Amended registration statement | Mar 3, 2025 | — |
| S-1/A | Amended registration statement | Feb 26, 2025 | — |
| S-1 | Registration statement | Feb 10, 2025 | — |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- KMTS (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- Bermuda
- Headquarters
- Kirkland, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1877184
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.